| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0950-351X(05)80271-X |
| P698 | PubMed publication ID | 8435058 |
| P2093 | author name string | Newnham HH | |
| P2860 | cites work | Hormonal contraceptive increases plasma lipid peroxides in female rats. Relationship to platelet aggregation and lipid biosynthesis | Q69325861 |
| Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit | Q69355830 | ||
| Growth of human aortic smooth muscle cells cultured with human serum is retarded when serum lipids are lowered by medroxyprogesterone | Q70040939 | ||
| Lipoprotein predictors of the severity of coronary artery disease in men and women | Q70085437 | ||
| Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study | Q70102309 | ||
| Biologic effects of transdermal estradiol | Q70140885 | ||
| Population-based lipoprotein lipid reference values for pregnant women compared to nonpregnant women classified by sex hormone usage | Q70388918 | ||
| The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females | Q70437748 | ||
| L-norgestrel and progesterone have different influences on plasma lipoproteins | Q70455289 | ||
| The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women | Q71377804 | ||
| Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-b | Q71522804 | ||
| On the metabolic function of heparin-releasable liver lipase | Q72604985 | ||
| Estrogen in patients with prostatic cancer. An assessment of the risks and benefits | Q28276648 | ||
| Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase | Q28330981 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study | Q34184063 | ||
| Menopause and the risk of coronary heart disease in women | Q34184268 | ||
| Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys | Q34215194 | ||
| Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans | Q34256239 | ||
| Plasma high density lipoproteins. Metabolism and relationship to atherogenesis | Q34257420 | ||
| Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women | Q34563528 | ||
| Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence | Q34748119 | ||
| Healthy life expectancy: evaluation of global indicator of change in population health | Q35178838 | ||
| Lipoprotein (a) concentrations in postmenopausal women taking norethisterone | Q35180738 | ||
| Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study | Q35707484 | ||
| Peripheral blood flow in menopausal women who have hot flushes and in those who do not. | Q35712570 | ||
| Sex hormones, lipoproteins, and cardiovascular risk | Q36997673 | ||
| Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women | Q37460438 | ||
| Estrogen and coronary heart disease in women | Q37670617 | ||
| Approaches to lipid and lipoprotein analysis | Q37786739 | ||
| Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review | Q37860081 | ||
| Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis | Q37865099 | ||
| Ovarian hormones and the circulation | Q37966148 | ||
| Lipoproteins and atherogenesis. Current concepts | Q37995527 | ||
| Postmenopausal estrogen use and coronary atherosclerosis | Q39296621 | ||
| The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results | Q39552111 | ||
| The pathogenesis of atherosclerosis--an update | Q39726917 | ||
| Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review | Q39732386 | ||
| Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis | Q39756776 | ||
| Controversies concerning the safety of estrogen replacement therapy | Q39766842 | ||
| High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study | Q40070458 | ||
| Changes in lipoprotein composition during the menstrual cycle | Q40233352 | ||
| Treatment of Post-Menopausal Hypercholerolaemia with Estradiol | Q40283859 | ||
| Risk factors and noncontraceptive estrogen use in women with and without coronary disease | Q41311262 | ||
| Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence. Correlation with plasma testosterone levels | Q41382116 | ||
| A prospective study of postmenopausal estrogen therapy and coronary heart disease | Q41504638 | ||
| Estrogens inhibit copper and cell-mediated modification of low density lipoprotein | Q41671984 | ||
| Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias. | Q41692355 | ||
| Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women | Q42153247 | ||
| Oxidized LDL affects multiple atherogenic cellular responses | Q43519125 | ||
| A study of the hypolipidemic effect of estrogen in type III hyperlipoproteinemia | Q68742973 | ||
| Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient | Q68831507 | ||
| Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women | Q68926605 | ||
| Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum | Q68936238 | ||
| Effect of menstrual cycle phase on plasma lipids | Q69061648 | ||
| Pregnancy-associated inhibition of coronary artery atherosclerosis in monkeys. Evidence of a relationship with endogenous estrogen | Q69113742 | ||
| Menopause and risk factors for coronary heart disease | Q69153876 | ||
| Effects of treatment with oestradiol/levonorgestrel on bone, lipoproteins and hormone status in postmenopausal women | Q69274400 | ||
| Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women | Q43567251 | ||
| Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study | Q43776201 | ||
| A randomized comparison of nonoral estradiol delivery in postmenopausal women | Q43856587 | ||
| Synergistic effects of lipid transfers and hepatic lipase in the formation of very small high-density lipoproteins during incubation of human plasma | Q43947968 | ||
| Sodium oleate dissociates the heteroexchange of cholesteryl esters and triacylglycerol between HDL and triacylglycerol-rich lipoproteins | Q44045487 | ||
| Hyperlipidemic arterial dysfunction | Q44071911 | ||
| Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis | Q44096359 | ||
| Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis | Q44121998 | ||
| Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins | Q44181135 | ||
| Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects | Q44202268 | ||
| Premenopausal determinants of menopausal estrogen use. | Q44308102 | ||
| Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women | Q44423640 | ||
| Postmenopausal estrogen and prevention bias | Q44449587 | ||
| Estrogen modulates responses of atherosclerotic coronary arteries | Q44614248 | ||
| Effects of Conjugated Equine Estrogen With and Without Three Different Progestogens on Lipoproteins, High-Density Lipoprotein Subfractions, and Apolipoprotein A-I | Q44678362 | ||
| The triglyceride issue: a view from Framingham | Q44822390 | ||
| Hepatic lipase activity during oral and parenteral 17 beta-estradiol replacement therapy: high-density lipoprotein increase may not be antiatherogenic | Q44856785 | ||
| Postmenopausal oestrogen and cardioprotection | Q44887100 | ||
| Postmenopausal use of estrogen and occlusion of coronary arteries | Q44902825 | ||
| Reproductive history in women with coronary heart disease. A case-control study | Q45064311 | ||
| Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern. | Q45188593 | ||
| Changes in lipids and lipoproteins with long-term estrogen deficiency and hormone replacement therapy. | Q45984207 | ||
| Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. | Q46036570 | ||
| Metabolic regulation of plasma apolipoprotein E by estrogen and progesterone in the baboon (Papio sp). | Q46480811 | ||
| Comparison of Continuous Versus Sequential Estrogen and Progestin Therapy in Postmenopausal Women | Q46659987 | ||
| Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. | Q52626803 | ||
| Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. | Q53895919 | ||
| Massive hyperlipemia during estrogen therapy. | Q53943706 | ||
| A comparison of the effects of ethinyl estradiol and estradiol valerate on serum and lipoprotein lipids. | Q54119146 | ||
| Biological Effects of Various Doses of Vaginally Administered Conjugated Equine Estrogens in Postmenopausal Women* | Q55062476 | ||
| High-dose synthetic progestogens inhibit foam and smooth muscle cell proliferation and atherosclerotic plaque formation in aortas of rabbits fed a hypercholesterolemic diet | Q59157235 | ||
| Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations | Q64356865 | ||
| Apo A-I metabolism in cynomolgus monkeys: male-female differences | Q67275096 | ||
| Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity | Q67769877 | ||
| Effect of continuous oestradiol-medroxyprogesterone administration on plasma lipids and lipoproteins | Q67927670 | ||
| Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits | Q67993789 | ||
| Progesterone modulates the expression of HDL binding sites in human skin fibroblasts | Q68011340 | ||
| Effects of tamoxifen on cardiovascular risk factors in postmenopausal women | Q68060159 | ||
| Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp.). | Q68183274 | ||
| Changes in Plasma Lipoprotein and Apolipoprotein Composition in Relation to OralVersusPercutaneous Administration of Estrogen Alone or in Cyclic Association with Utrogestan in Menopausal Women | Q68246089 | ||
| Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause | Q68319189 | ||
| Relationship of endogenous sex steroid hormones to lipids and apoproteins in postmenopausal women | Q68366743 | ||
| Influence of menopause on serum lipids and lipoproteins | Q68371103 | ||
| Differences in Low Density Lipoprotein Subfractions and Apolipoproteins in Premenopausal and Postmenopausal Women* | Q68393057 | ||
| Comparison of two hormone replacement regimens--influence on lipoproteins and bone mineral content | Q68434679 | ||
| Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added dydrogesterone | Q68494077 | ||
| Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B | Q68564239 | ||
| Influence of estrogens on serum free fatty acid levels in women | Q68586046 | ||
| Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women | Q68610300 | ||
| Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone | Q68610409 | ||
| P433 | issue | 1 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 61-93 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Bailliere's clinical endocrinology and metabolism | Q27709241 |
| P1476 | title | Oestrogens and atherosclerotic vascular disease--lipid factors | |
| P478 | volume | 7 |
| Q37197085 | A comparative study of lipid profile and oestradiol in pre- and post-menopausal women |
| Q61387330 | Changes in plasma lipids and lipoproteins associated with starting or stopping postmenopausal hormone replacement therapy |
| Q37438227 | Circulating levels of monocyte chemoattractant protein-1 and interleukin-7 in women who have undergone bilateral salpingo-oophorectomy |
| Q41371037 | Coronary heart disease. Women's hearts are hard to break |
| Q43267040 | Current state of hormone replacement therapy: the case for using trimegestone |
| Q33273984 | ESTs from a wild Arachis species for gene discovery and marker development |
| Q33750997 | Micronized progesterone: clinical indications and comparison with current treatments |
| Q70930526 | Plasma changes in breast cancer patients during endocrine therapy--lipid measurements and nuclear magnetic resonance (NMR) spectroscopy |
| Q36695459 | Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids |
| Q43577849 | The effects of hormone replacement therapy on lipid peroxidation and antioxidant status |
Search more.